Bio Essence Corporation
BIOE
$0.206
-$0.008-3.74%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 324.00K | -28.70K | -7.70K | 210.20K | 551.50K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 324.00K | -28.70K | -7.70K | 210.20K | 551.50K |
| Cost of Revenue | 106.90K | 66.20K | 148.00K | 285.40K | 285.40K |
| Gross Profit | 217.10K | 110.20K | 49.40K | 129.90K | 129.90K |
| SG&A Expenses | 676.40K | 190.90K | 330.90K | 473.10K | 345.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 49.30K | 49.30K | 49.30K | -- | -- |
| Total Operating Expenses | 832.60K | 21.00K | 242.70K | 473.00K | 345.50K |
| Operating Income | -508.60K | -259.90K | -460.60K | -473.00K | -345.50K |
| Income Before Tax | -1.57M | -1.32M | -436.50K | -502.90K | -403.00K |
| Income Tax Expenses | 800.00 | -800.00 | -800.00 | 1.60K | 1.60K |
| Earnings from Continuing Operations | -1.57 | -1.32 | -0.44 | -0.50 | -0.40 |
| Earnings from Discontinued Operations | 256.90K | -154.60K | -154.60K | -154.60K | -567.30K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.31M | -1.48M | -590.30K | -659.10K | -971.80K |
| EBIT | -508.60K | -259.90K | -460.60K | -473.00K | -345.50K |
| EBITDA | -507.60K | -289.40K | -473.80K | -470.30K | -340.80K |
| EPS Basic | -0.03 | -0.04 | -0.02 | -0.02 | -0.03 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.03 | -0.04 | -0.02 | -0.02 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 152.04M | 147.98M | 147.98M | 144.68M | 139.68M |
| Average Diluted Shares Outstanding | 152.04M | 147.98M | 147.98M | 144.68M | 139.68M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |